1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Autoimmune Injectables Market to 2020

Autoimmune Injectables Market to 2020

  • June 2014
  • -
  • Greystone Research Associates

In spite of the growing understanding of the underlying disease mechanisms for a host of diseases and disease families, autoimmune conditions continue to be intractable to most therapies and difficult to treat. Because of the individual genetic variability underlying the incidence and severity of autoimmune symptoms, regional variations in the market for autoimmune therapeutics can be significant. This variability is compounded by differences in treatment protocols and cultural factors, which combine to make alliance partnerships with regional players of increasing importance. Over the past two years the introduction of new and improved injectables for treating autoimmune diseases is creating new options for clinicians and patients. This optimism is being reinforced by pipeline candidates that will further the effort to improve treatment protocols for patients.

Highlights

- Analyzes current therapeutic options for autoimmune diseases, and evaluates emerging therapeutic candidates and assesses their commercial potential

- Assesses existing and evolving immune disease mechanisms, treatment strategies and pipeline drug candidates

- Provides data and forecasts for major autoimmune disease segments to 2020

- Evaluates regional and global opportunities for autoimmune therapeutics

Table Of Contents

Autoimmune Injectables Market to 2020
Executive Summary

Immune Modulation in Disease Therapeutics

Evolving Models of Disease and Human Health
The Immune Response in Disease Incidence, Treatment and Prevention
The Immune Cascade
Receptors, Ligands and Cell Signaling Pathways

Autoimmune Disease Therapeutics- Commercial Realities

FDA-Approved Drugs
Patient and Disease Demographics
Competitive Landscape
Factors Limiting Growth
Regulatory Factors
Cost per Dose and Managed Care
Side Effects, Black Box Warnings and Patient Compliance

Autoimmune Disease Therapeutics - Disease Segment Analysis

Arthritis
Psoriasis
Multiple Sclerosis
Crohn's Disease
Lupus

Autoimmune Injectables - Indications, Market Data and Forecasts

TNF
Growth Factor inhibitors
Interleukins
Interferons
T-Cell Receptor Inhibitors
Innate Immune Cell Receptor Inhibitors
B-Cell Receptor Inhibitors
Kinase Inhibitors
Co-stimulator Inhibitors
Chemokine Receptors
Transcription Factors
Vascular Adhesion Inhibitors
Toll-like Receptors
Other Immune Factor Drug Candidates

Business Factors

Regulatory Factors
Clinical Trial Protocols and Endpoints
Alliances and Partnerships

Autoimmune Injectables- Company Profile

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • December 2016
  • by GlobalData

PharmaPoint: Psoriatic Arthritis - Global Drug Forecast and Market Analysis to 2025 Summary Psoriatic arthritis (PsA) is a chronic immune-mediated arthritis typically affecting the large joints, especially ...

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

Human Microbiome Market by Indication, Application, Product, Product Research, Technology Research - Global Forecast to 2025

  • $ 5650
  • Industry report
  • March 2017
  • by MarketsandMarkets

The global human microbiome market is estimated to reach USD 899.1 million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025) Factors such as increased focus on human microbiome ...

Ankylosing spondylitis (AS)- Market Insights, Epidemiology and Market Forecast-2023

Ankylosing spondylitis (AS)- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • January 2017
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Ankylosing spondylitis (AS) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease ...


Download Unlimited Documents from Trusted Public Sources

Diabetes Statistics in China

  • March 2017
    13 pages
  • Diabetes  

  • China  

View report >

Lymphoma Statistics in Germany

  • March 2017
    167 pages
  • Lymphoma  

    Cancer  

    Leukemia  

  • Germany  

    Europe  

    United States  

View report >

Cardiovascular Disease Statistics in the US

  • March 2017
    8 pages
  • Cardiovascular ...  

  • United States  

View report >

Related Market Segments :

Autoimmune Disease

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.